[breadcrumb_custom]

TRACON Pharmaceuticals Inc Inc. (TCON) Price Performance: A Fundamental Analysis Perspective

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price loss of -88.36% this year. Over the last six months, there has been a stronger performance of -71.08%. The price of TCON fallen by 10.65% during the last 30 days period. For the last 5-days stocks have slided -18.93%.

The present stock price for TRACON Pharmaceuticals Inc (TCON) is $0.17. In the last trading session, the stock made a considerable jump, reaching $0.209 after an opening price of $0.195. The stock briefly fell to $0.1637 before ending the session at $0.17.

TRACON Pharmaceuticals Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $2.19 on 03/29/23, while the lowest price for the same duration was marked at $0.13 on 10/10/23.

52-week price history of TCON Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. TRACON Pharmaceuticals Inc’s current trading price is -92.08% away from its 52-week high, while its distance from the 52-week low is 38.25%. The stock’s price range during this time has been between $0.13 and $2.19. The trading volume for the Healthcare sector company’s shares reached about 17.18 million for the day, which was higher than the average daily volume of 2.4 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

TRACON Pharmaceuticals Inc (TCON) has experienced a quarterly decline of -34.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.40M and boasts a workforce of 18 employees.

TRACON Pharmaceuticals Inc: Analysts’ Ratings Unveiled

As of right now, 1 analyst is rating TRACON Pharmaceuticals Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2316, with a change in price of -0.1295. Similarly, TRACON Pharmaceuticals Inc recorded 1,944,508 in trading volume during the last 100 days, posting a change of -42.74%.

TCON Stock Stochastic Average

Today’s raw stochastic average for TRACON Pharmaceuticals Inc over the last 50 days is 23.47%.This indicates a increase from the raw stochastic average of the past 20 days, which was 21.36%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 18.14% and 18.28%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts